Your browser doesn't support javascript.
loading
Brief Report: Safety and Antitumor Activity of Alectinib Plus Atezolizumab From a Phase 1b Study in Advanced ALK-Positive NSCLC.
Kim, Dong-Wan; Gadgeel, Shirish; Gettinger, Scott N; Riely, Gregory J; Oxnard, Geoffrey R; Mekhail, Tarek; Schmid, Peter; Dowlati, Afshin; Heist, Rebecca S; Wozniak, Antoinette J; Singh, Jatinder; Cha, Edward; Spahn, Jessica; Ou, Sai-Hong Ignatius.
Affiliation
  • Kim DW; Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, South Korea.
  • Gadgeel S; Department of Internal Medicine, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan.
  • Gettinger SN; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, Connecticut.
  • Riely GJ; Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Oxnard GR; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Mekhail T; AdventHealth Cancer Institute, Orlando, Florida.
  • Schmid P; Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Dowlati A; Division of Hematology and Oncology, University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, Ohio.
  • Heist RS; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Wozniak AJ; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Singh J; Genentech, Inc., South San Francisco, California.
  • Cha E; Genentech, Inc., South San Francisco, California.
  • Spahn J; Genentech, Inc., South San Francisco, California.
  • Ou SI; University of California Irvine School of Medicine, Orange, California.
JTO Clin Res Rep ; 3(8): 100367, 2022 Aug.
Article in En | MEDLINE | ID: mdl-35875467
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JTO Clin Res Rep Year: 2022 Document type: Article Affiliation country: South Korea Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JTO Clin Res Rep Year: 2022 Document type: Article Affiliation country: South Korea Country of publication: United States